Correlation Between Molecular Templates and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Molecular Templates and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Rigel Pharmaceuticals.
Diversification Opportunities for Molecular Templates and Rigel Pharmaceuticals
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Molecular and Rigel is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Molecular Templates i.e., Molecular Templates and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Molecular Templates and Rigel Pharmaceuticals
Given the investment horizon of 90 days Molecular Templates is expected to generate 17.59 times less return on investment than Rigel Pharmaceuticals. In addition to that, Molecular Templates is 2.11 times more volatile than Rigel Pharmaceuticals. It trades about 0.01 of its total potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.32 per unit of volatility. If you would invest 1,452 in Rigel Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 1,218 from holding Rigel Pharmaceuticals or generate 83.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Molecular Templates |
| Rigel Pharmaceuticals |
Molecular Templates and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Rigel Pharmaceuticals
The main advantage of trading using opposite Molecular Templates and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Molecular Templates vs. Eliem Therapeutics | Molecular Templates vs. Scpharmaceuticals | Molecular Templates vs. Milestone Pharmaceuticals | Molecular Templates vs. Seres Therapeutics |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |